Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | GABRP | O00591 | 2/20 | 0.43 |
| ▸ | GABRD | O14764 | 2/20 | 0.43 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.43 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.43 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.43 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.43 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.43 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.43 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.43 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.43 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.43 |
| ▸ | GABRE | P78334 | 2/20 | 0.43 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.43 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.43 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.43 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27416805 | 1.00 | CYP1A2 (0.54) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL11420328 | 1.00 | CYP1A2 (0.54) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL27533855 | 0.85 | CYP1A2 (0.42) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL31364339 | 0.85 | FFAR4 (0.47) | MEN1KMT2ATSHRNFKB1 | |
| SCHEMBL16660376 | 0.84 | CYP2D6 (0.37) | CYP1A2MEN1KMT2AGAANOS1 | |
| SCHEMBL15984252 | 0.84 | CYP2D6 (0.37) | CYP1A2MEN1KMT2AGAANOS1 | |
| SCHEMBL15373759 | 0.82 | NOS1 (0.35) | CYP1A2MEN1KMT2AGAANOS1 | |
| SCHEMBL28276395 | 0.82 | FOLH1 (0.41) | CYP1A2GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL28718237 | 0.81 | KMT2A (0.39) | MEN1KMT2AGAANOS1NOS3 | |
| SCHEMBL14593930 | 0.81 | KMT2A (0.39) | MEN1KMT2AGAANOS1NOS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230366885-A1 | DNA CONSTRUCTS, RECOMBINANT CELLS COMPRISING THEREOF, BACTERIAL PROBES, METHODS FOR THEIR PREPARATION, AND METHOD OF USING THEREOF | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2023-11-16 | — | — | US | disclosed |
| US-20230151360-A1 | NUCLEIC ACID COMPLEX AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2023-05-18 | — | — | US | disclosed |
| US-8138145-B2 | Hybrid oligomers, their preparation process and pharmaceutical compositions containing them | Centre National de la Recherche Scientifique (SNRS) (FR) | 2012-03-20 | — | — | US | disclosed |
| US-20100298206-A1 | HYBRID OLIGOMERS, THEIR PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), I.B.M.C. (FR) | 2010-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298206-A1 | HYBRID OLIGOMERS, THEIR PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | NOD2, NOD1, COG5 | CYP1A2 3686/4885GABRP 1004/4885GABRD 2727/4885 |
| US-20230151360-A1 | NUCLEIC ACID COMPLEX AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | SNRPA, NSUN2, NSUN3 | CYP1A2 4708/4885GABRP 2510/4885GABRD 2587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.